These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A. Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944 [Abstract] [Full Text] [Related]
28. Neural correlates of impaired performance on the clock drawing test in Alzheimer's disease. Nagahama Y, Okina T, Suzuki N, Nabatame H, Matsuda M. Dement Geriatr Cogn Disord; 2005 Nov; 19(5-6):390-6. PubMed ID: 15802915 [Abstract] [Full Text] [Related]
30. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter. DeCarli C, Grady CL, Clark CM, Katz DA, Brady DR, Murphy DG, Haxby JV, Salerno JA, Gillette JA, Gonzalez-Aviles A, Rapoport SI. J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):158-67. PubMed ID: 8708645 [Abstract] [Full Text] [Related]
31. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing. Gilman S, Koeppe RA, Little R, An H, Junck L, Giordani B, Persad C, Heumann M, Wernette K. Exp Neurol; 2005 Feb; 191 Suppl 1():S95-S103. PubMed ID: 15629765 [Abstract] [Full Text] [Related]
32. Visuoconstructive performance and regional cerebral glucose metabolism in Alzheimer's disease. Ober BA, Jagust WJ, Koss E, Delis DC, Friedland RP. J Clin Exp Neuropsychol; 1991 Sep; 13(5):752-72. PubMed ID: 1955530 [Abstract] [Full Text] [Related]